TCF4 and cancer: As reported by others, WNT5A, LBH, WISP1 and TCF4 were expressed at lower levels in ER+ cell lines compared to ER-ve cancer but also compared to immortalised normal breast cell lines (Figure 1A), perhaps reflecting their ER-ve status.